553 related articles for article (PubMed ID: 24966382)
1. Endogenous opioid-induced neuroplasticity of dopaminergic neurons in the ventral tegmental area influences natural and opiate reward.
Pitchers KK; Coppens CM; Beloate LN; Fuller J; Van S; Frohmader KS; Laviolette SR; Lehman MN; Coolen LM
J Neurosci; 2014 Jun; 34(26):8825-36. PubMed ID: 24966382
[TBL] [Abstract][Full Text] [Related]
2. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM
J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032
[TBL] [Abstract][Full Text] [Related]
3. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.
Kaufling J; Aston-Jones G
J Neurosci; 2015 Jul; 35(28):10290-303. PubMed ID: 26180204
[TBL] [Abstract][Full Text] [Related]
4. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.
Baimel C; Borgland SL
J Neurosci; 2015 May; 35(18):7295-303. PubMed ID: 25948277
[TBL] [Abstract][Full Text] [Related]
5. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
[TBL] [Abstract][Full Text] [Related]
6. Differential disruption of conditioned ejaculatory preference in the male rat based on different sensory modalities by micro-infusions of naloxone to the medial preoptic area or ventral tegmental area.
Quintana GR; Birrel M; Marceau S; Kalantari N; Bowden J; Bachoura Y; Borduas E; Lemay V; Payne JW; Cionnaith CM; Pfaus JG
Psychopharmacology (Berl); 2019 Dec; 236(12):3613-3623. PubMed ID: 31359118
[TBL] [Abstract][Full Text] [Related]
7. The mesolimbic system participates in the naltrexone-induced reversal of sexual exhaustion: opposite effects of intra-VTA naltrexone administration on copulation of sexually experienced and sexually exhausted male rats.
Garduño-Gutiérrez R; León-Olea M; Rodríguez-Manzo G
Behav Brain Res; 2013 Nov; 256():64-71. PubMed ID: 23933468
[TBL] [Abstract][Full Text] [Related]
8. Myelin plasticity in the ventral tegmental area is required for opioid reward.
Yalçın B; Pomrenze MB; Malacon K; Drexler R; Rogers AE; Shamardani K; Chau IJ; Taylor KR; Ni L; Contreras-Esquivel D; Malenka RC; Monje M
Nature; 2024 Jun; 630(8017):677-685. PubMed ID: 38839962
[TBL] [Abstract][Full Text] [Related]
9. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
[TBL] [Abstract][Full Text] [Related]
10. VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward.
Liu X; Li Y; Yu L; Vickstrom CR; Liu QS
Neuropsychopharmacology; 2018 Apr; 43(5):1066-1077. PubMed ID: 29039413
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
Ahmad T; Laviolette SR
Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
[TBL] [Abstract][Full Text] [Related]
12. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
[TBL] [Abstract][Full Text] [Related]
13. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
14. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.
Mazei-Robison MS; Koo JW; Friedman AK; Lansink CS; Robison AJ; Vinish M; Krishnan V; Kim S; Siuta MA; Galli A; Niswender KD; Appasani R; Horvath MC; Neve RL; Worley PF; Snyder SH; Hurd YL; Cheer JF; Han MH; Russo SJ; Nestler EJ
Neuron; 2011 Dec; 72(6):977-90. PubMed ID: 22196333
[TBL] [Abstract][Full Text] [Related]
15. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
16. The effects of AMPA receptor blockade in the prelimbic cortex on systemic and ventral tegmental area opiate reward sensitivity.
De Jaeger X; Bishop SF; Ahmad T; Lyons D; Ng GA; Laviolette SR
Psychopharmacology (Berl); 2013 Feb; 225(3):687-95. PubMed ID: 22972411
[TBL] [Abstract][Full Text] [Related]
17. Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects.
Pan B; Zhong P; Sun D; Liu QS
J Neurosci; 2011 Aug; 31(31):11244-55. PubMed ID: 21813685
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area.
Liu C; Fang X; Wu Q; Jin G; Zhen X
Neuropharmacology; 2015 Aug; 95():299-308. PubMed ID: 25882828
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the role of muscarinic M
Li X; Zheng Y; Zhao X; Cui R; Li X
Neurosci Lett; 2022 Aug; 786():136774. PubMed ID: 35809878
[TBL] [Abstract][Full Text] [Related]
20. Determination of circuit-specific morphological adaptations in ventral tegmental area dopamine neurons by chronic morphine.
Simmons SC; Wheeler K; Mazei-Robison MS
Mol Brain; 2019 Feb; 12(1):10. PubMed ID: 30736837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
